The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the book describes for example these two doctors at the Cleveland Clinic who began to piece together that some of their patients who and these are cardiac drugs were stabilized on the brand and then became unstable when they were switched to the generic and in some cases heart transplant patients were suffering organ rejection from a generic tech alumnus yeah the tacrolimus
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.